Key Takeaways From Schrodinger Analyst Ratings

Loading...
Loading...

During the last three months, 4 analysts shared their evaluations of Schrodinger SDGR, revealing diverse outlooks from bullish to bearish.

The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.

Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
Total Ratings 1 2 1 0 0
Last 30D 0 1 0 0 0
1M Ago 1 0 0 0 0
2M Ago 0 1 0 0 0
3M Ago 0 0 1 0 0

Analysts have set 12-month price targets for Schrodinger, revealing an average target of $41.5, a high estimate of $51.00, and a low estimate of $35.00. Highlighting a 9.78% decrease, the current average has fallen from the previous average price target of $46.00.

Breaking Down Analyst Ratings: A Detailed Examination

In examining recent analyst actions, we gain insights into how financial experts perceive Schrodinger. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
Steven Mah TD Cowen Announces Outperform $42.00 -
Matt Hewitt Craig-Hallum Lowers Buy $35.00 $40.00
Scott Schoenhaus Keybanc Announces Overweight $38.00 -
Vikram Malhorta Morgan Stanley Lowers Equal-Weight $51.00 $52.00

Key Insights:

Loading...
Loading...
  • Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Schrodinger. This information provides a snapshot of how analysts perceive the current state of the company.
  • Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Schrodinger compared to the broader market.
  • Price Targets: Analysts gauge the dynamics of price targets, providing estimates for the future value of Schrodinger's stock. This comparison reveals trends in analysts' expectations over time.

Navigating through these analyst evaluations alongside other financial indicators can contribute to a holistic understanding of Schrodinger's market standing. Stay informed and make data-driven decisions with our Ratings Table.

Stay up to date on Schrodinger analyst ratings.

If you are interested in following small-cap stock news and performance you can start by tracking it here.

All You Need to Know About Schrodinger

Schrodinger Inc is a healthcare-based software company. Its operating segments are Software and Drug discovery. Through the Software segment, the company is focused on selling software to transform drug discovery across the life sciences industry and customers in materials science industries. In the Drug discovery segment, it is engaged in generating revenue from a portfolio of preclinical and clinical programs, internally and through collaborations. It generates revenue from the sales of software solutions and from research funding and milestone payments from its drug discovery collaborations.

Schrodinger's Economic Impact: An Analysis

Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.

Revenue Growth: Over the 3 months period, Schrodinger showcased positive performance, achieving a revenue growth rate of 15.11% as of 30 September, 2023. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.

Net Margin: Schrodinger's net margin is below industry standards, pointing towards difficulties in achieving strong profitability. With a net margin of -145.7%, the company may encounter challenges in effective cost control.

Return on Equity (ROE): Schrodinger's ROE excels beyond industry benchmarks, reaching -10.56%. This signifies robust financial management and efficient use of shareholder equity capital.

Return on Assets (ROA): Schrodinger's ROA lags behind industry averages, suggesting challenges in maximizing returns from its assets. With an ROA of -7.58%, the company may face hurdles in achieving optimal financial performance.

Debt Management: Schrodinger's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.23.

How Are Analyst Ratings Determined?

Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.

Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.

If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in Benzinga Pro.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In: Analyst RatingsBZI-AAR
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...